Provided by Tiger Trade Technology Pte. Ltd.

Icon PLC

169.99
-0.3600-0.21%
Post-market: 169.990.00000.00%19:30 EDT
Volume:851.06K
Turnover:143.54M
Market Cap:13.11B
PE:309.74
High:170.40
Open:167.98
Low:165.24
Close:170.35
52wk High:203.91
52wk Low:66.57
Shares:77.15M
Float Shares:76.74M
Volume Ratio:0.66
T/O Rate:1.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.5488
EPS(LYR):2.71
ROE:0.29%
ROA:0.97%
PB:1.40
PE(LYR):62.73

Loading ...

Icon Price Target Raised to $209.00/Share from $207.00 by Truist Securities

Dow Jones
·
Jul 31

ICON Plc : Leerink Partners Raises Target Price to $186.00 from $180.00

THOMSON REUTERS
·
Jul 31

ICON Plc : Baird Raises Target Price to $194 from $192

THOMSON REUTERS
·
Jul 31

Movement Alert|Icon PLC Falls 5.65% in Regular Trading, Q2 Beat Overshadowed by Wide Full-Year EPS Guidance Range

Market Focus
·
Jul 31

ICON Faces Expanded US Securities Class Action, Adds CFO and Ex-employee as Defendants

Reuters
·
Jul 30

ICON PLC Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 30

Analysts’ Top Healthcare Picks: Icon (ICLR), Biogen (BIIB)

TIPRANKS
·
Jul 30

GUIDANCE: (ICLR) Icon Expects 2026 Adjusted EPS Range $10 - $11, vs. FactSet Est of $10.64

MT Newswires Live
·
Jul 30

GUIDANCE: (ICLR) Icon Reaffirms 2026 Revenue Guidance Range $7.85 Billion-$8.15 Billion, vs. FactSet Est of $8.06 Billion

MT Newswires Live
·
Jul 30

ICON Q2 FY26 GAAP EPS Drops 63.28% to $0.94; Revenue Rises 1.2% to $2.06 Billion vs Q2 FY25

Reuters
·
Jul 30

Clinical Research Firm ICON's Q2 Revenue Rises 1.2%, Beats Analyst Estimates

Reuters
·
Jul 30

Icon Q2 Adj. EPS $2.56 Beats $2.52 Estimate, Sales $2.063B Beat $2.006B Estimate

Benzinga Earnings
·
Jul 30

ICON: Reaffirming Full-Year Financial Guidance Issued with REV $7,850 - $8,150 Mln, Adj Diluted Earnings Per Share $10.00 - $11.00

THOMSON REUTERS
·
Jul 30

ICON Q2 Net Income USD 72.582 Million

THOMSON REUTERS
·
Jul 30

Press Release: ICON Reports Second Quarter 2026 Results

Dow Jones
·
Jul 30

Movement Alert|Icon PLC Rises 10.18% in Regular Trading, Announces Multi-Year AI Partnership with Anthropic

Market Focus
·
Jul 28

Icon, Anthropic Collaborating to Integrate Artificial Intelligence Into Clinical Trials

MT Newswires Live
·
Jul 28

ICON Partners with Anthropic to Deploy Claude AI Across Clinical Trial Operations

Reuters
·
Jul 28

To Develop Site Intelligence and Study Planning Capabilities with Anthropic AI

THOMSON REUTERS
·
Jul 28

ICON Announces Multi-Year Collaboration with Anthropic to Bring Frontier AI to Clinical Trials

THOMSON REUTERS
·
Jul 28